Stay updated on MK-3475+Laser+Ablation in Gliomas Clinical Trial
Sign up to get notified when there's something new on the MK-3475+Laser+Ablation in Gliomas Clinical Trial page.

Latest updates to the MK-3475+Laser+Ablation in Gliomas Clinical Trial page
- CheckyesterdayNo Change Detected
- Check9 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.0%
- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedThe web page has been updated to reflect that patients in the phase II trial will no longer be randomized and will instead receive MLA followed by MK-3475 treatment. Additionally, the principal investigator's name has been added, and the revision number has been updated.SummaryDifference39%
- Check30 days agoChange DetectedThe page has been updated to reflect the submission of results and has been revised to version 2.14.4.SummaryDifference0.1%
- Check37 days agoChange DetectedThe web page has been updated from version 2.14.2 to version 2.14.3.SummaryDifference0.0%
- Check66 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference0.8%
- Check88 days agoChange DetectedThe page now includes a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference0.8%
Stay in the know with updates to MK-3475+Laser+Ablation in Gliomas Clinical Trial
Enter your email address, and we'll notify you when there's something new on the MK-3475+Laser+Ablation in Gliomas Clinical Trial page.